Cargando…
Glycated Hemoglobin (HbA1c) as a Biomarker for Diabetic Foot Peripheral Neuropathy
Background: Diabetic peripheral neuropathy (DPN) is known to predict foot ulceration, lower-extremity amputation and mortality. Patients with diabetes mellitus have a predisposition toward developing chronic inflammatory demyelinating polyneuropathy, and this may also facilitate the formation of dia...
Autores principales: | Casadei, Giulia, Filippini, Marta, Brognara, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006047/ https://www.ncbi.nlm.nih.gov/pubmed/33671807 http://dx.doi.org/10.3390/diseases9010016 |
Ejemplares similares
-
The Association between Cognitive Impairment and Diabetic Foot Care: Role of Neuropathy and Glycated Hemoglobin
por: Brognara, Lorenzo, et al.
Publicado: (2020) -
Glycated Hemoglobin (HbA1c): Clinical Applications of a Mathematical Concept
por: Leow, Melvin Khee Shing
Publicado: (2016) -
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction
por: Zuccato, Cristina, et al.
Publicado: (2012) -
Correlation of Fasting Blood Sugar and Glycated Hemoglobin (HbA1c) With Thiamine Levels in Diabetic Patients
por: Khan, Muhammad Ulusyar, et al.
Publicado: (2023) -
HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients
por: Su, Jian-bin, et al.
Publicado: (2018)